Rapid Identification of Clinical Yeast Isolates by Mass Spectrometry

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

1. 1.
   Chen SCA, Marriott D, Playford EG, et al.: Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 2009, 15:662–669.CrossRefPubMedGoogle Scholar
2. 2.
   Barker KS, Rogers PD: Recent insights into the mechanisms of antifungal resistance. Curr Infect Dis Rep 2006, 8:449–456.CrossRefPubMedGoogle Scholar
3. 3.
   Hazen KC, Howell SA: Candida, Cryptococcus, and other yeasts of medical importance. In Manual of Clinical Microbiology, edn 9. Edited by Murray PR, Baron EJ, Jorgensen JH, et al. Washington, DC: American Society for Microbiology; 2007:1762–1788.Google Scholar
4. 4.
   Anhalt JP, Fenselau C: Identification of bacteria using mass-spectrometry. Anal Chem 1975, 47:219–225.CrossRefGoogle Scholar
5. 5.
   Cain TC, Lubman DM, Weber WJ: Differentiation of bacteria using protein profiles from matrix-assisted laser/desorption ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1994, 8:1026–1030.CrossRefGoogle Scholar
6. 6.
   Claydon MA, Davey SN, Edwards-Jones V, Gordon DB: The rapid identification of intact microorganisms using mass spectrometry. Nat Biotechnol 1996, 14:1584–1586.CrossRefPubMedGoogle Scholar
7. 7.
   Holland RD, Wilkes JG, Rafii F, et al.: Rapid identification of intact whole bacteria based on spectral patterns using matrix-assisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1996, 14:911–917.CrossRefGoogle Scholar
8. 8.
   Krishnamurthy T, Ross PL, Rajamani U: Detection of pathogenic and non-pathogenic bacteria by matrix assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1996, 10:883–888.CrossRefPubMedGoogle Scholar
9. 9.
   Li TY, Liu BH, Chen YC: Characterization of Aspergillus spores by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2000, 14:2393–2400.CrossRefPubMedGoogle Scholar
10. 10.
    Welham KJ, Domin MA, Johnson K, et al.: Characterization of fungal spores by laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2000, 14:307–310.CrossRefPubMedGoogle Scholar
11. 11.
    Amiri-Eliasi B, Fenselau C: Characterization of protein biomarkers desorbed by MALDI from whole fungal cells. Anal Chem 2001, 73:5228–5231.CrossRefPubMedGoogle Scholar
12. 12.
    Ahmed FE: Utility of mass spectrometry for proteome analysis: part 1. Conceptual and experimental approaches. Expert Rev Proteomics 2008, 5:841–864.CrossRefPubMedGoogle Scholar
13. 13.
    • Sauer S, Kliem M: Mass spectrometry tools for the classification and identification of bacteria. Nat Rev Microbiol 2010, 8:74–82. This is an excellent review of mass spectrometry methods for the classification and identification of bacteria and fungi.CrossRefPubMedGoogle Scholar
14. 14.
    Bernardo K, Pakulat N, Macht M, et al.: Identification and discrimination of Staphylococcus aureus strains using matrix-assisted laser desorption/ionization–time of flight mass spectrometry. Proteomics 2002, 2:747–753.CrossRefPubMedGoogle Scholar
15. 15.
    Hathout Y, Demirev PA, Ho YP, et al.: Identification of Bacillus spores by matrix assisted laser desorption ionization mass spectrometry. Appl Environ Microbiol 1999, 65:4313–4319.PubMedGoogle Scholar
16. 16.
    Ilina EN, Borovskaya AD, Malakhova MM, et al.: Direct bacterial profiling by matrix assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria. J Mol Diagn 2009, 11:75–86.CrossRefPubMedGoogle Scholar
17. 17.
    Dieckmann R, Helmuth R, Erhard M, Malorny B: Rapid classification and identification of Salmonellae at the species and subspecies levels by whole-cell matrix-assisted laser desorption ionization–time of flight mass spectrometry. Appl Environ Microbiol 2008, 74:7767–7778.CrossRefPubMedGoogle Scholar
18. 18.
    Winkler MA, Uher J, Cepa S: Direct analysis and identification of Helicobacter and Campylobacter species by MALDI-TOF mass spectrometry. Anal Chem 1999, 71:3416–3419.CrossRefPubMedGoogle Scholar
19. 19.
    Nagy E, Maier T, Urban E, et al.: Species identification of clinical isolates of Bacteroides by matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry. Clin Microbiol Infect 2009, 15:796–802.CrossRefPubMedGoogle Scholar
20. 20.
    Pitarch A, Abian J, Carrascal M, et al.: Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004, 4:3084–3106.CrossRefPubMedGoogle Scholar
21. 21.
    Thomas DP, Viudes A, Monteagudo C, et al.: A proteomic-based approach for the identification of Candida albicans protein components present in a subunit vaccine that protects against disseminated candidiasis. Proteomics 2006, 6:6033–6041.CrossRefPubMedGoogle Scholar
22. 22.
    Hettick JM, Green BJ, Buskirk AD, et al.: Discrimination of Aspergillus isolates at the species and strain level by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Anal Biochem 2008, 380:276–281.CrossRefPubMedGoogle Scholar
23. 23.
    Hettick JM, Green BJ, Buskirk AD, et al.: Discrimination of Penicillium isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry fingerprinting. Rapid Commun Mass Spectrom 2008, 22:2555–2560.CrossRefPubMedGoogle Scholar
24. 24.
    Seyfarth F, Ziemer M, Sayer HG, et al.: The use of ITS DNA sequence analysis and MALDI-TOF mass spectrometry in diagnosing an infection with Fusarium proliferatum. Exp Derm 2008, 17:965–971.CrossRefPubMedGoogle Scholar
25. 25.
    Degand N, Carbonnelle E, Dauphin B, et al.: Matrix-assisted laser desorption ionization–time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol 2008, 46:3361–3367.CrossRefPubMedGoogle Scholar
26. 26.
    • Marklein G, Josten M, Klanke U, et al.: Matrix-assisted laser desorption ionization–time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates. J Clin Microbiol 2009, 47:2912–2917. This is the first large study demonstrating that MALDI-TOF MS can be used to identify a broad spectrum of clinical isolates of yeast accurately and rapidly.CrossRefPubMedGoogle Scholar
27. 27.
    Mellmann A, Cloud J, Maier T, et al.: Evaluation of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in comparison to 16 S rRNA gene sequencing for species identification of nonfermenting bacteria. J Clin Microbiol 2008, 46:1946–1954.CrossRefPubMedGoogle Scholar
28. 28.
    Mellmann A, Bimet F, Bizet C, et al.: High interlaboratory reproducibility of matrix-assisted laser desorption ionization time of flight mass spectrometry-based species identification of nonfermenting bacteria. J Clin Microbiol 2009, 47:3732–3734.CrossRefPubMedGoogle Scholar
29. 29.
    Seng P, Drancourt M, Gouriet F, et al.: Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis 2009, 49:543–551.CrossRefPubMedGoogle Scholar
30. 30.
    Parisi D, Magliulo M, Nanni P, et al.: Analysis and classification of bacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and a chemometric approach. Anal Bioanal Chem 2008, 391:2127–2134.CrossRefPubMedGoogle Scholar
31. 31.
    • van Veen SQ, Claas ECJ, Kuijper EJ: High-throughput identification of bacteria and yeast by matrix-assisted laser desorption ionization–time of flight mass spectrometry in conventional medical microbiology laboratories. J Clin Microbiol 2010, 48:900–907. This study demonstrated that a broad spectrum of bacteria and yeast could be identified by MS. The inability to identify an organism was associated with the absence of sufficient spectra from reference organisms, so the current limitation of the procedure is development of a comprehensive clinical database.CrossRefPubMedGoogle Scholar
32. 32.
    Findeisen P, Sismanidis D, Riedl M, et al.: Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005, 51:2409–2411.CrossRefPubMedGoogle Scholar
33. 33.
    • Qian J, Cutler JE, Cole RB, Cai Y: MALDI-TOF mass signatures for differentiation of yeast species, strain grouping and monitoring of morphogenesis markers. Anal Bioanal Chem 2008, 392:439–449. This study is a systematic analysis of the variables that influence the reproducibility of MALDI-TOF MS profiles for the differentiation and subtyping of fungi.CrossRefPubMedGoogle Scholar
34. 34.
    •• Freiwald A, Sauer S: Phylogenetic classification and identification of bacteria by mass spectrometry. Nat Protoc 2009, 4:732–742. This report is a series of step-by-step protocols for sample preparation, cell wall disruption and protein extraction, and MALDI-TOF MS analysis for the identification of organisms.CrossRefPubMedGoogle Scholar
35. 35.
    Evason DJ, Claydon MA, Gordon DB: Exploring the limits of bacterial identification by intact cell mass spectrometry. J Am Soc Mass Spectrom 2001, 12:49–54.CrossRefPubMedGoogle Scholar
36. 36.
    Schuerenberg M, Luebbert C, Eickhoff H, et al.: Prestructured MALDI-MS sample supports. Anal Chem 2000, 72:3436–3442.CrossRefPubMedGoogle Scholar
37. 37.
    Tu T, Gross ML: Miniaturizing sample spots for matrix-assisted laser desorption/ionization mass spectrometry. Trends Anal Chem 2009, 28:833–841.CrossRefGoogle Scholar
38. 38.
    Fenselau C, Demirev PA: Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrom Rev 2001, 20:157–171.CrossRefPubMedGoogle Scholar
39. 39.
    Ryzhov V, Fenselau C: Characterization of the protein subset desorbed by MALDI from whole bacterial cells. Anal Chem 2001, 73:746–750.CrossRefPubMedGoogle Scholar
40. 40.
    Arnold RJ, Karty JA, Ellington AD, et al.: Monitoring the growth of a bacteria culture by MALDI-MS of whole cells. Anal Chem 1999, 71:1990–1996.CrossRefPubMedGoogle Scholar
41. 41.
    Saenz AJ, Petersen CE, Valentine NB, et al.: Reproducibility of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for replicate bacterial culture analysis. Rapid Commun Mass Spectrom 1999, 13:1580–1585.CrossRefPubMedGoogle Scholar
42. 42.
    Valentine N, Wunschel S, Wunschel D, et al.: Effect of culture conditions on microorganism identifications by matrix-assisted laser desorption ionization mass spectrometry. Appl Env Microbiol 2005, 71:58–64.CrossRefGoogle Scholar
43. 43.
    Wang Z, Russon L, Li L, et al.: Investigation of spectral reproducibility in direct analysis of bacteria proteins by matrix-assisted laser désorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1998, 12:456–464.CrossRefPubMedGoogle Scholar
44. 44.
    Hsieh S-Y, Tseng C-L, Lee Y-S, et al.: Highly efficient classification and identification of human pathogenic bacteria by MALDI-TOFMS. Mol Cell Proteomics 2008, 7:448–456.PubMedGoogle Scholar
45. 45.
    Stevenson LG, Drake SK, Murray PR: Rapid identification of bacteria in positive blood culture broths by matrix-assisted laser desorption ionization–time of flight mass spectrometry. J Clin Microbiol 2010, 48:444–447.CrossRefPubMedGoogle Scholar
46. 46.
    Rogers PD, Vermitsky JP, Edlind TD, Hilliard GM: Proteomic analysis of experimentally induced azole resistance in Candida glabrata. J Antimicrob Chemother 2006, 58:434–438.CrossRefPubMedGoogle Scholar
47. 47.
    •• Marinach C, Alanio A, Palous M, et al.: MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics 2009, 9:4627–4631. This study is a proof-of-concept demonstration that MALDI-TOF MS can be used to perform antifungal susceptibility tests with results equivalent to the Clinical Laboratory Standards Institute’s reference method.CrossRefPubMedGoogle Scholar